Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19

Strong infectivity enables coronavirus disease 2019 (COVID-19) to rage throughout the world. Moreover, the lack of drugs with definite therapeutic effects further aggravates the spread of the pandemic. Remdesivir is one of the most promising anti-severe acute respiratory syndrome coronavirus 2 (SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingjing, Zhang, Kai, Wu, Di, Ren, Lianjie, Chu, Xinyu, Qin, Chao, Han, Xiaopeng, Hang, Taijun, Xu, Yungen, Yang, Lei, Yin, Lifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2021
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529908/
https://www.ncbi.nlm.nih.gov/pubmed/34703490
http://dx.doi.org/10.1016/j.ajps.2021.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529908/
https://www.ncbi.nlm.nih.gov/pubmed/34703490
http://dx.doi.org/10.1016/j.ajps.2021.09.002

Ejemplares similares